Chemotherapy, Adjuvant Concept

subject area of

• 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years  Academic Article
• 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer  Academic Article
• HER2and Responsiveness of Breast Cancer to Adjuvant Chemotherapy  Academic Article
• neu/erbB-2 Overexpression and Response to Hormonal Therapy in Premenopausal Women in the Adjuvant Breast Cancer Setting: Will It Play in Peoria? Part II  Academic Article
• A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen  Academic Article
• A Bedside Decision Instrument To Elicit a Patient's Preference Concerning Adjuvant Chemotherapy for Breast Cancer  Academic Article
• A Challenging Question Regarding the Use of Topical Corticosteroids for Mycosis Fungoides  Academic Article
• A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer  Academic Article
• A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer  Academic Article
• A Multicenter Phase II Study of “Adjuvant” Irinotecan Following Resection of Colorectal Hepatic Metastases  Academic Article
• A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer  Academic Article
• A Risk Model to Predict the Delivery of Adjuvant Chemotherapy Following Lung Resection in Patients With Pathologically Positive Lymph Nodes  Academic Article
• A Translational Study of the Neoplastic Cells of Giant Cell Tumor of Bone Following Neoadjuvant Denosumab  Academic Article
• A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment  Academic Article
• A controlled ‘before-after’ study: impact of a clinical guidelines programme and regional cancer network organization on medical practice  Academic Article
• A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes  Academic Article
• A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial  Academic Article
• A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer  Academic Article
• A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia  Academic Article
• A priori Prediction of Neoadjuvant Chemotherapy Response and Survival in Breast Cancer Patients using Quantitative Ultrasound  Academic Article
• A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer  Academic Article
• A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada—Clinical Trials Group Trial, MA.12)  Academic Article
• A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer  Academic Article
• A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma  Academic Article
• A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma  Academic Article
• ASO Visual Abstract: Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower-Extremity Sarcomas—Does Timing Impact Complication Rates?  Academic Article
• Activity of fulvestrant in HER2-overexpressing advanced breast cancer  Academic Article
• Adjunctive antiarrhythmic drug therapy in patients with implantable cardioverter defibrillators: a systematic review  Academic Article
• Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection  Academic Article
• Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection  Academic Article
• Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients  Academic Article
• Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  Academic Article
• Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation  Academic Article
• Adjuvant Chemotherapy With or Without Biologics Including Antiangiogenics and Monoclonal Antibodies Targeting EGFR and EpCAM in Colorectal Cancer: A Systematic Review and Meta-analysis  Academic Article
• Adjuvant Chemotherapy for Breast Cancer — 30 Years Later  Academic Article
• Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review  Academic Article
• Adjuvant Endocrine Therapy for Postmenopausal Women with Early Breast Cancer  Conference Paper
• Adjuvant Endocrine Therapy in Hormone Receptor-Positive Postmenopausal Breast Cancer: Evolution of NCCN, ASCO, and St Gallen Recommendations  Academic Article
• Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial  Academic Article
• Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update  Academic Article
• Adjuvant Therapy for Breast Cancer: We Are Solving the Puzzle, But Pieces Are Still Missing  Academic Article
• Adjuvant Therapy for Premenopausal Women With Breast Cancer: Is It Time for Another Paradigm Shift?  Academic Article
• Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site Group  Academic Article
• Adjuvant Therapy for completely resected Stage II Colon Cancer  Academic Article
• Adjuvant Trastuzumab Therapy: Can We Balance Efficacy and Safety?  Academic Article
• Adjuvant Treatment and Onset of Menopause Predict Weight Gain After Breast Cancer Diagnosis  Academic Article
• Adjuvant Treatment in Non-Small Cell Lung Cancer: Where Are We Now?  Academic Article
• Adjuvant and extended adjuvant use of aromatase inhibitors: Reducing the risk of recurrence and distant metastasis  Academic Article
• Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials  Academic Article
• Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial  Academic Article
• Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data  Academic Article
• Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome  Academic Article
• Adjuvant chemotherapy in colorectal carcinoma  Conference Paper
• Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials  Academic Article
• Adjuvant endocrine therapies for pre-/perimenopausal women  Academic Article
• Adjuvant endocrine therapy of breast cancer  Academic Article
• Adjuvant hormonal therapy for premenopausal breast cancer: incorporating clinical experience.  Academic Article
• Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial  Academic Article
• Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial  Academic Article
• Adjuvant systemic therapy for breast cancer: a tale of relapse and survival  Academic Article
• Adjuvant targeted therapy in early breast cancer  Academic Article
• Adjuvant therapy and thrombosis: How to avoid the problem?  Academic Article
• Adjuvant therapy for early breast cancer: where do we stand today?  Academic Article
• Adjuvant therapy for resected non-small-cell lung cancer: Past, present, and future  Academic Article
• Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.  Academic Article
• Adjuvant therapy of the very young woman  Conference Paper
• Adjuvant trastuzumab for HER2-positive breast cancer  Academic Article
• Adjuvant treatment for endometrial cancer: Literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO)  Academic Article
• Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: A systematic review  Academic Article
• Advancing fertility-sparing treatments in cervical cancer: Where is the limit?  Academic Article
• Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol  Academic Article
• American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer  Academic Article
• American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting  Academic Article
• American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004  Academic Article
• American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002  Academic Article
• American Society of Clinical Oncology Technology Assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004  Academic Article
• An anatomical‐based mapping analysis of the pancreaticoduodenectomy retroperitoneal margin highlights the urgent need for standardized assessment  Academic Article
• An update on adjuvant systemic therapy for elderly patients with early breast cancer  Academic Article
• Anastrozole as an Adjuvant Endocrine Treatment for Postmenopausal Patients with Breast Cancer: Emerging Data  Conference Paper
• Are HER2 and TOP2A Useful As Prognostic or Predictive Biomarkers for Anthracycline-Based Adjuvant Chemotherapy for Breast Cancer?  Academic Article
• Aromatase Inhibitors in Adjuvant Therapy of Breast Cancer: Before, Instead of, or Beyond Tamoxifen  Academic Article
• Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer  Academic Article
• Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review  Academic Article
• Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials  Academic Article
• Ascertaining Prognosis for Breast Cancer in Node-Negative Patients with Innovative Survival Analysis  Academic Article
• Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study  Academic Article
• Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer  Academic Article
• Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study  Academic Article
• Breast cancer: the real challenge  Academic Article
• Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.  Academic Article
• Can the Therapeutic Gain of Radiotherapy Be Increased by Concurrent Administration of Asian Botanicals?  Academic Article
• Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo  Academic Article
• Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline  Academic Article
• Cardiac and Inflammation Biomarker Profile after Initiation of Adjuvant Trastuzumab Therapy  Academic Article
• Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial  Academic Article
• Cervical Cancer During Pregnancy  Academic Article
• Chemotherapy-Response Monitoring of Breast Cancer Patients Using Quantitative Ultrasound-Based Intra-Tumour Heterogeneities  Academic Article
• Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial  Academic Article
• Clinical Decision Making vs Programme Evaluation Perspectives  Academic Article
• Clinical Impact of Residual Extraretroperitoneal Masses in Patients With Advanced Nonseminomatous Germ Cell Testicular Cancer  Academic Article
• Clinical Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced Penile Squamous-Cell Carcinoma: Results of a Multicenter Analysis  Academic Article
• Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer  Academic Article
• Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer.  Academic Article
• Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply.  Academic Article
• Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer  Academic Article
• Clinical cooperative trials of the National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.  Academic Article
• Clinical cooperative trials of the national cancer institute of Canada clinical trials group breast cancer site group  Conference Paper
• Clinical trial update: National Cancer Institute of Canada  Academic Article
• Colorectal Cancer in Young Adults  Academic Article
• Combined pancreaticoduodenectomy and colon resection for locally advanced peri-ampullary tumours: analysis of peri-operative morbidity and mortality  Academic Article
• Combining endocrine agents with chemotherapy: Which patients and what sequence?  Conference Paper
• Commentary: Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era?  Academic Article
• Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor–Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial  Academic Article
• Comparison of patients with renal cell carcinoma in adjuvant therapy trials to a real-world population  Academic Article
• Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials  Academic Article
• Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27  Academic Article
• Consolidation Therapy With Autologous Bone Marrow Transplantation in Adults With Acute Myeloid Leukemia: A Meta-analysis  Academic Article
• Consumer impact of an interactive decision aid for rectal cancer patients offered adjuvant therapy  Academic Article
• Coping with uncertainty: T1a,bN0M0 HER2-positive breast cancer, do we have a treatment threshold?  Academic Article
• Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia  Academic Article
• Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer  Academic Article
• Decision-Making Process--Communicating Risk/Benefits: Is There an Ideal Technique?  Academic Article
• Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer  Academic Article
• Disabling Encephalopathy During 5-Fluorouracil and Levamisole Adjuvant Therapy for Resected Colorectal Cancer: A Report of Two Cases  Academic Article
• Does routine symptom screening with ESAS decrease ED visits in breast cancer patients undergoing adjuvant chemotherapy?  Academic Article
• Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12  Academic Article
• Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial  Academic Article
• Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate  Academic Article
• Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17  Academic Article
• Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor–Treated Patients: CCTG MA.27  Academic Article
• Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93  Academic Article
• Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial  Academic Article
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials  Academic Article
• Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17  Conference Paper
• Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17  Academic Article
• Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings  Academic Article
• Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies  Academic Article
• Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women  Academic Article
• Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination  Academic Article
• Epigenetic therapy inhibits metastases by disrupting premetastatic niches  Academic Article
• Epirubicin in Breast Cancer: Present and Future  Academic Article
• Esophageal gastrointestinal stromal tumor: report of 7 patients  Academic Article
• European oncologists' preferences for the management of breast cancer: case presentations and expert commentary  Academic Article
• Evaluating the Feasibility of Performing Window of Opportunity Trials in Breast Cancer  Academic Article
• Evaluating the benefits of exercise for women receiving adjuvant therapy for breast cancer: research challenges.  Academic Article
• Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer  Academic Article
• Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.  Conference Paper
• Evidence-Based Recommendations Against Neoadjuvant Chemotherapy for Routine Management of Patients with Squamous Cell Head and Neck Cancer  Academic Article
• Evidence-based guideline recommendations on treatment strategies for localized Ewing's sarcoma of bone following neo-adjuvant chemotherapy  Academic Article
• Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions  Academic Article
• Extended adjuvant therapy: the role of subset analyses  Academic Article
• Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years  Academic Article
• Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists  Academic Article
• Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient‐reported outcomes substudy  Academic Article
• Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study  Academic Article
• GnRH Analogues and Ovarian Ablation: Their Integration in the Adjuvant Strategy  Academic Article
• HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data  Academic Article
• HER2/neu in systemic therapy for women with breast cancer: a systematic review  Academic Article
• Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer  Academic Article
• Health-Related Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer--Taking Stock  Academic Article
• Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer  Academic Article
• High non-compliance in the use of letrozole after 2.5years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial  Academic Article
• Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy  Academic Article
• Immediate Post–Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non–Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review  Academic Article
• Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials  Academic Article
• Impact of germlineBRCA1mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma  Academic Article
• Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials  Academic Article
• Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole  Academic Article
• Impact of the addition of chemotherapy to radiotherapy for oropharyngeal cancer in 2003-2004: Population-based study from the Province of Ontario, Canada  Academic Article
• Incidence and Prognostic Impact of Amenorrhea During Adjuvant Therapy in High-Risk Premenopausal Breast Cancer: Analysis of a National Cancer Institute of Canada Clinical Trials Group Study—NCIC CTG MA.5  Academic Article
• Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy  Academic Article
• Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial  Academic Article
• Integration of Chinese medicine into supportive cancer care:A modern role for an ancient tradition  Academic Article
• Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17  Academic Article
• Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy  Academic Article
• Laparoscopic vs. open abdominoperineal resection for cancer  Academic Article
• Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen  Academic Article
• Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases  Academic Article
• Long-Term Efficacy of Modified-Release Recombinant Human Thyrotropin Augmented Radioiodine Therapy for Benign Multinodular Goiter: Results from a Multicenter, International, Randomized, Placebo-Controlled, Dose-Selection Study  Academic Article
• Long-Term Follow-Up of Women in Trials of Adjuvant Therapy for Breast Cancer: Is It Still Important?  Academic Article
• Long-term Followup of a Randomized Trial of 0 Versus 3 Months of Neoadjuvant Androgen Ablation Before Radical Prostatectomy  Academic Article
• Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy  Academic Article
• Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials  Academic Article
• Lung cancer.  Academic Article
• Lung cancer.  Academic Article
• Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues  Academic Article
• Managing patients on endocrine therapy: Focus on quality-of-life issues  Conference Paper
• Melanoma in children and the use of sentinel lymph node biopsy  Conference Paper
• Melatonin as Adjuvant Cancer Care With and Without Chemotherapy  Academic Article
• Metastatic testicular tumor requiring inferior vena cava resection  Academic Article
• More Evidence That Locoregional Radiation Therapy Improves Survival: What Should We Do?  Academic Article
• NCCN Task Force Report: Adjuvant Therapy for Breast Cancer  Academic Article
• Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower Extremity Sarcomas: Does Timing Impact Complication Rates?  Academic Article
• Neoadjuvant Chemotherapy for Transitional Cell Carcinoma of the Bladder: A Systematic Review and Meta-Analysis  Academic Article
• Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review  Academic Article
• Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America  Academic Article
• Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline.  Academic Article
• Neuroendocrine Tumors of the Gastrointestinal Tract  Academic Article
• New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole – Analyses from NCIC CTG MA.17  Academic Article
• OSTEOSARCOMA AND PULMONARY METASTASES: 15-YEAR EXPERIENCE FROM A SINGLE INSTITUTION  Academic Article
• Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer  Conference Paper
• Oligodendroglioma  Academic Article
• Opinions in pediatric and adolescent gynecology  Academic Article
• Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05)  Academic Article
• Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration  Academic Article
• Oral Corticosteroid Therapy as an Adjuvant Treatment for Acute Bleeding in Hemophilia Patients With High Titer Inhibitors  Academic Article
• Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27  Academic Article
• Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation  Academic Article
• Ovarian ablation as adjuvant therapy for early-stage breast cancer  Academic Article
• Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer  Academic Article
• Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations.  Academic Article
• PREDICTORS OF PATHOLOGICAL STAGE BEFORE NEOADJUVANT ANDROGEN WITHDRAWAL THERAPY AND RADICAL PROSTATECTOMY  Academic Article
• Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx  Academic Article
• Patients’ Preferences for Therapy in Advanced Epithelial Ovarian Cancer: Development, Testing, and Application of a Bedside Decision Instrument  Academic Article
• Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma  Academic Article
• Pediatric thalamic tumors in the MRI era: a Canadian perspective  Academic Article
• Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome  Academic Article
• Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013  Academic Article
• Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response  Academic Article
• Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer  Academic Article
• Physician/Patient Decision Aids for Adjuvant Therapy  Academic Article
• Polychemotherapy for early breast cancer: an overview of the randomised trials  Academic Article
• Postmenopausal breast cancer: is the short-term pain worth the long-term gain?  Academic Article
• Postneoadjuvant Pure and Predominantly Pure Intralymphatic Breast Carcinoma  Academic Article
• Postoperative Adjuvant Systemic Therapy in Completely Resected Non–Small-Cell Lung Cancer: A Systematic Review  Academic Article
• Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker  Academic Article
• Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical Trials  Academic Article
• Predictors of attendance to an oncologist-referred exercise program for women with breast cancer  Academic Article
• Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies  Academic Article
• Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival  Academic Article
• Primary Care Versus Oncology-Based Surveillance Following Adjuvant Chemotherapy in Resected Pancreatic Cancer  Academic Article
• Primary small cell carcinoma of the cecum  Academic Article
• Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model  Academic Article
• Prognostic Significance of Supradiaphragmatic Lymphadenopathy Identified on Preoperative Computed Tomography Scan in Patients Undergoing Primary Cytoreduction for Advanced Epithelial Ovarian Cancer  Academic Article
• Prognostic factors for women with Stage 1 ovarian cancer with or without adhesions.  Academic Article
• Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System  Academic Article
• Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario  Academic Article
• Prospective Evaluation of the Impact of the 21-Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node-Positive Breast Cancer in Ontario, Canada  Academic Article
• Prospective Validation of a 21-Gene Expression Assay in Breast Cancer  Academic Article
• Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001–2009)  Academic Article
• Quantitative Analysis of Clinical Dynamic Contrast-enhanced MR Imaging for Evaluating Treatment Response in Human Breast Cancer  Academic Article
• Quantitative Ultrasound Evaluation of Tumor Cell Death Response in Locally Advanced Breast Cancer Patients Receiving Chemotherapy  Academic Article
• Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach  Academic Article
• Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.  Academic Article
• Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival  Academic Article
• Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17  Academic Article
• Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14  Academic Article
• Re: Earle et al., effect of lymph node retrieval rates on utilization of adjuvant chemotherapy in stage II colon cancer  Academic Article
• Reasons for Delay in Time to Initiation of Adjuvant Chemotherapy for Colon Cancer  Academic Article
• Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative  Academic Article
• Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial  Academic Article
• Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial  Academic Article
• Review of the Clinical Studies Using the 21-Gene Assay  Academic Article
• Risk of Acute Leukemia Following Epirubicin-Based Adjuvant Chemotherapy: A Report From the National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Risk of Menopause During the First Year After Breast Cancer Diagnosis  Academic Article
• Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study  Academic Article
• Role of Adjuvant Therapy in Esophageal Cancer Patients After Neoadjuvant Therapy and Esophagectomy  Academic Article
• Second Primary Malignancy Risk in Thyroid Cancer Survivors: A Systematic Review and Meta-Analysis  Academic Article
• Selection of adjuvant chemotherapy for treatment of node-positive breast cancer  Academic Article
• Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer1  Conference Paper
• Shared Treatment Decision Making: What Does It Mean to Physicians?  Academic Article
• Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)  Academic Article
• Strain Rate Imaging Detects Early Cardiac Effects of Pegylated Liposomal Doxorubicin as Adjuvant Therapy in Elderly Patients with Breast Cancer  Academic Article
• Subcortical brain iron deposition and cognitive performance in older women with breast cancer receiving adjuvant chemotherapy: A pilot MRI study  Academic Article
• Subgroup Analyses: When Should We Believe Them?  Academic Article
• Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: A systematic review and meta-analysis of randomised controlled trials  Academic Article
• Surgery for early stage cervical cancer: How radical should it be?  Academic Article
• Surgical outcomes in women with ovarian cancer.  Academic Article
• Survival outcomes of patients with advanced oral cavity squamous cell carcinoma treated with multimodal therapy: a multi-institutional analysis  Academic Article
• Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer  Academic Article
• Systematic review of adjuvant care for women with Stage I ovarian carcinoma  Academic Article
• Systemic Adjuvant Therapy for Adult Patients at High Risk for Recurrent Cutaneous or Mucosal Melanoma: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline  Academic Article
• Systemic adjuvant therapy for adult patients at high risk for recurrent melanoma: A systematic review  Academic Article
• Systemic therapy in squamous cell carcinoma of the vulva: Current status and future directions  Academic Article
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy  Academic Article
• TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients  Academic Article
• Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015  Academic Article
• Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status  Academic Article
• Tamoxifen added to adjuvant chemotherapy in premenopausal women with early breast cancer: is it standard practice or still a subject for study?  Academic Article
• The Prognostic Value of Tumor Regression Grades Combined With TNM Classification in Patients With Muscle-Invasive Bladder Cancer Who Underwent Neoadjuvant Chemotherapy Followed by Radical Cystectomy  Academic Article
• The association between endocrine therapy use and dementia among post-menopausal women treated for early-stage breast cancer in Ontario, Canada  Academic Article
• The association between endocrine therapy use and osteoporotic fracture among post-menopausal women treated for early-stage breast cancer in Ontario, Canada  Academic Article
• The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer  Academic Article
• The best use of adjuvant endocrine treatments  Conference Paper
• The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation  Academic Article
• The extended adjuvant NCIC CTG MA.17 trials: Initial and rerandomization studies  Academic Article
• The physician–patient encounter: The physician as a perfect agent for the patient versus the informed treatment decision-making model  Academic Article
• The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis  Academic Article
• Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy  Academic Article
• Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy  Academic Article
• Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial  Academic Article
• Towards optimal endocrine therapy for hormone-sensitive breast cancer: Initial versus sequential adjuvant aromatase inhibition  Academic Article
• Treatment Modality and Trends in Survival for Gallbladder Cancer: a Population-Based Study  Academic Article
• Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration  Academic Article
• Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma  Academic Article
• Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol  Conference Paper
• Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial  Academic Article
• Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial  Academic Article
• Trends in endocrine therapy and chemotherapy for early breast cancer: a focus on the premenopausal patient  Academic Article
• Triamcinolone Acetonide as Adjunctive Treatment to Verteporfin in Neovascular Age-Related Macular Degeneration  Academic Article
• Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer  Academic Article
• Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.  Academic Article
• Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline  Academic Article
• Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update  Academic Article
• Use of human dura in pediatric chest wall reconstruction after tumor resection  Conference Paper
• Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27  Academic Article
• Weight gain in breast cancer survivors: prevalence, pattern and health consequences  Academic Article
• Women's perceptions of home-based exercise performed during adjuvant chemotherapy for breast cancer  Academic Article